Webinars

觀看網路研討會 - 07 六月 2022

Accelerating clinical development in China & the US

China and the US are the world’s largest oncology research destinations, and the clinical research bridge between them supports accelerated clinical development from early to late phase trials while ensuring the inclusion of MRCT data packages in future regulatory applications.

觀看網路研討會 - 20 五月 2022

Development and Regulatory Strategy for US and China

This webinar discusses the expansion of International Market for Ensartini and RNAi Therapeutics in Oncology, from Skin Cancers to Liver Cancers. Additionally, it aims to understand the Evolving U.S. regulatory requirements for diversity in clinical cancer trials.

觀看網路研討會 - 13 五月 2022

Go/No Go Decisions Based on Early Phase Oncology Trials

Understanding the latest regulatory and clinical developments in the field of Oncology in China, along with discussing the similarities and differences between Chinese oncology market and the overall global market, promote academic exchange and cooperation of the global oncology research and development ecosystem.

觀看網路研討會 - 22 十月 2021

Driving efficiencies through virtual trial solutions in Asia Pacific

What is driving the acceleration of clinical trials in the Asia Pacific region and what are key considerations to maximise the opportunity for decentralised clinical trials in the future across the region.

觀看網路研討會 - 13 九月 2021

Accelerating Clinical Trials in Rare Disease - Understanding Asia’s success as a rare disease clinical trial location

This webinar looks at Asia’s rare disease clinical trial landscape, why China is an increasingly attractive location for rare disease trials and critical program strategies to consider.

觀看網路研討會 - 14 七月 2021

Expedited clinical development strategies for China

A two-part webinar interview and panel discussion with exclusive insights into China’s regulatory environment, the advantages of involving China sites, and strategies to accelerate entry in China.

觀看網路研討會 - 26 三月 2021

Asia Pacific: The solution for accelerating your clinical trial program

Presented By Katrina Norial at OCT Southeast. In this presentation Katrina Norial discusses Novotech’s capabilities, ensuring clinical trial continuity during COVID-19 and leveraging regional advantages to accelerate development.

觀看網路研討會 - 21 三月 2021

The benefits of running clinical trials in China

During this webinar we will discuss how China offers a significant opportunity for biotech companies to accelerate their clinical development.

觀看網路研討會 - 18 十二月 2020

Achieving regulatory milestones & meeting commercial goals

Gain exclusive insight into the world of product development planning and regulatory affairs from industry experts to understand the importance of a streamlined and focused global program strategy.

觀看網路研討會 - 23 十月 2020

Managing Global Studies with Regional Partners

In this webinar, you'll learn about 1) Working with specialist CRO partners to maintain speed, flexibility, “fit” and regional expertise, 2) Leveraging technology and gold standard systems to provide integrated global management structure and reporting and 3) Advantages and tradeoffs of different global clinical trial setups.

觀看網路研討會 - 25 九月 2020

Accelerating Clinical Trials in Australia and Asia – Presented by Steven Roan at OCT USA

Steven Roan breaks down the acceleration of clinical trials in Australia and Asia. The presentation is broken into three main segments. An introduction to Novotech and how Asia-Pacific is handling the COVID-19 pandemic, what Novotech is doing to support companies in these times, and finally talking about the benefits of working in Asia-Pacific for clinical trials.

觀看網路研討會 - 12 八月 2020

Running First-in-human and Vaccines Studies in Australia

A US Investigational New Drug (IND) submission is not necessary to initiate first-in-human clinical trials in Australia. FIH trials in Australia are of high quality and are acceptable to other regulatory agencies in support of later Phase clinical trials.

聯絡

職涯

解決方案

資源

關於

Location Settings

Asia-Pacific

North America

GLOBAL

Location Settings

Asia-Pacific

North America

GLOBAL

Accelerating clinical development in China & the US

Development and Regulatory Strategy for US and China

Go/No Go Decisions Based on Early Phase Oncology Trials

Driving efficiencies through virtual trial solutions in Asia Pacific

Accelerating Clinical Trials in Rare Disease - Understanding Asia’s success as a rare disease clinical trial location

Expedited clinical development strategies for China

Asia Pacific: The solution for accelerating your clinical trial program

The benefits of running clinical trials in China

Achieving regulatory milestones & meeting commercial goals

Managing Global Studies with Regional Partners

Accelerating Clinical Trials in Australia and Asia – Presented by Steven Roan at OCT USA

Running First-in-human and Vaccines Studies in Australia

聯絡

Webinars

聯絡

職涯

CAREERS

解決方案

SOLUTIONS

資源

RESOURCES

關於

ABOUT US

Location Settings

Asia-Pacific

North America

GLOBAL

CAREERS

SOLUTIONS

RESOURCES

ABOUT US

Location Settings

Asia-Pacific

North America

GLOBAL

Accelerating clinical development in China & the US

Development and Regulatory Strategy for US and China

Go/No Go Decisions Based on Early Phase Oncology Trials

Driving efficiencies through virtual trial solutions in Asia Pacific

Accelerating Clinical Trials in Rare Disease - Understanding Asia’s success as a rare disease clinical trial location

Expedited clinical development strategies for China

Asia Pacific: The solution for accelerating your clinical trial program

The benefits of running clinical trials in China

Achieving regulatory milestones & meeting commercial goals

Managing Global Studies with Regional Partners

Accelerating Clinical Trials in Australia and Asia – Presented by Steven Roan at OCT USA

Running First-in-human and Vaccines Studies in Australia